Executive Summary

Investment Thesis: Sealed Air ($SEE) has just cleared a major regulatory hurdle for a pending acquisition by funds affiliated with Clayton, Dubilier & Rice, which sharply reduces transaction risk and concentrates near-term upside around the deal close. The company still shows attractive fundamentals, including a low-teens P/E, strong ROE, and recent earnings beats, suggesting the equity is trading with a favorable valuation cushion. That said, leverage, a sub-1 current ratio, and the potential for a fixed take-private price mean upside beyond the deal could be limited if the buyer sets a tight offer price.

Current Price: $41.97 | Key Metric: P/E Ratio 12.24 | Stance: BULLISH

Company Overview

Sealed Air Corporation ($SEE) is a global packaging company focused on protective packaging, food packaging and material handling solutions. The business serves food processors, e-commerce and industrial customers with a mix of products and engineered solutions that help protect goods in transport and extend shelf life of food products.

Key Products & Competitive Position

Core Business: Engineered protective packaging and food packaging solutions, with recurring demand from large industrial and food customers.
Key Products: Bubble cushioning and protective films, Cryovac food packaging films and machinery, automated packaging systems and related consumables.
Competitive Moat: Global scale in supply and distribution, proprietary material science and machinery tie-ins that create switching costs for large customers.

Recent Developments

On March 23, 2026, $SEE announced it has received all regulatory approvals required to complete a pending acquisition by funds affiliated with CD&R, with the transaction expected to close in April 2026. The company also reported a Q4 2025 earnings beat, with EPS of $0.77 versus an estimate of $0.7384. Management has maintained a generally consistent track record of cost discipline and margin improvement initiatives over the last several quarters.

Financial Snapshot

Market Cap$6.19B

P/E Ratio12.24

52-Week Range$22.78 - $44.27

Dividend Yield1.90%

EPS (TTM)$3.43

ROE48.39%

Revenue & Earnings Trends

$SEE generated roughly $5.3B in revenue over the last twelve months according to reported data, with trailing net income around $440M. Revenue has recovered materially since the 52-week low in April 2025, delivering a one-year total return north of 40%. Earnings have shown modest sequential improvement as cost controls and pricing actions offset raw material pressure in many end-markets.

Balance Sheet Highlights

The balance sheet shows a current ratio of 0.91, which signals modest near-term liquidity tightness relative to current liabilities. Total leverage has historically been elevated at the enterprise level, reflecting capital intensity and past acquisitions. Cash on hand is limited relative to gross debt, so financing flexibility may be constrained without asset sales, refinancing, or external capital support from a buyer.

Valuation Analysis

Current Valuation Metrics

Forward P/E12.5vs Industry: ~15

PEG Ratio0.59Growth-adjusted

EV/EBITDA10.06vs Historical: ~11.5

P/S Ratio1.15vs Peers: ~1.4

Historical Comparison

At a trailing P/E of ~12, $SEE trades below what would be expected for a stable industrial consumer-cyclical name in better years. EV/EBITDA at about 10 is slightly below the company's recent historical average, reflecting improved profitability and the market pricing in the pending acquisition. On a multiples basis the shares appear modestly cheap relative to the company's demonstrated ROE and cash generation.

Fair Value Estimate

Combining forward multiple work and a conservative DCF sensitivity, a fair value range centers around $44 to $50 per share under base case assumptions. That range factors in mid-single-digit organic growth, continued margin expansion through cost programs, and no large incremental capex shock. The consensus analyst mean price target of $45.36 sits inside that range, implying around an 8% upside from todays price, while the acquisition process may compress or expand realized upside depending on final offer mechanics.

Competitive Landscape

Market Position

Market Share: Material share in protective and food packaging markets | Ranking: Top 3 in several global segments

Key Competitors

$AVYAvery Dennison, material science and labeling, diversified packaging exposure

$AMCRAmcor, global flexible packaging leader with broad food and pharma exposure

$BERYBerry Global, blow-molded and flexible packaging with scale in consumer markets

Competitive Advantages

Moat 1: Scale across manufacturing and distribution lowers cost and increases bargaining power with large food and industrial customers.
Moat 2: Integrated product-plus-equipment offerings create recurring consumable demand and switching friction.
Moat 3: Established relationships with large food processors and e-commerce customers provide stable volumes and referential wins.

Earnings Track Record

Last 4 Quarters: 3 beats / 1 miss

Recent Earnings History

Q4 2025$0.77 vs $0.7384 estBEAT

Q3 2025$0.90 vs $0.87 estBEAT

Q2 2025$0.65 vs $0.70 estMISS

Q1 2025$0.85 vs $0.80 estBEAT

Guidance Trend

Management has emphasized margin recovery and cash flow generation. Guidance has generally trended toward conservative targets that were often exceeded by execution and pricing actions. With the pending transaction, public guidance may be minimal or capped as the deal progresses and the company transitions to new ownership.

Analyst Sentiment

Consensus Rating: Buy

Strong Buy: 2 Buy: 5 Hold: 9 Sell: 1

Price Targets

Low: $42.00
Mean: $45.36 (+8.1% upside)
High: $52.00

Recent Analyst Actions

Truist maintained a Buy and raised its price target to $49 on January 6, 2026. The consensus view is constructive, though nearly half of analysts are on Hold, reflecting differing opinions on post-deal upside and margin durability.

Recent News & Catalysts

Key Developments

Regulatory Approvals Secured: Sealed Air received all required regulatory approvals to complete the pending acquisition by funds affiliated with CD&R, and the transaction is expected to close in April 2026. This materially lowers deal execution risk.
Q4 2025 Results: EPS beat with $0.77 versus an estimate of $0.7384, highlighting ongoing margin and cost management progress.
Price Recovery: Shares have rallied from a low near $22.78 in April 2025 to the mid-$40s, reflecting both operational recovery and takeover interest.

Upcoming Catalysts

Next Earnings: Expected 2026-05-04 Before Market | Key Events: Completion of acquisition in April, any supplemental disclosure around deal mechanics, Q1 2026 earnings and updated analyst commentary

Technical Outlook

Current Price: $41.97 vs 52-Week High: $44.27 (-5.2% from high)

Trend Analysis

Price action has trended higher since the April 2025 low, with momentum picking up as the acquisition process advanced. The stock currently trades in a tight range near $42, and near-term direction is likely to be driven by deal-close headlines and any last-minute disclosure about transaction terms.

Key Levels

Resistance: $44.30, $48.00
Support: $38.00, $32.00

Bull vs Bear Case

Bull Case

Catalyst 1: Acquisition closing removes execution risk and likely delivers a near-term premium to public shareholders if the offer is priced attractively.
Catalyst 2: Continued margin improvement and pricing power drive earnings upgrades and validate a higher multiple.
Catalyst 3: Current valuation multiples are below historical averages, leaving room for re-rating if private equity value creation plans are disclosed.

Bull Target: $52 (+24%)

Bear Case

Risk 1: The take-private transaction may be priced close to current levels, capping upside for public shareholders once the deal closes.
Risk 2: High leverage and sub-1 current ratio raise liquidity and refinancing risks during economic slowdowns.
Risk 3: Input cost volatility and cyclical demand could compress margins if pricing cannot fully offset cost increases.

Bear Target: $30 (-28%)

Risks to Consider

Valuation Risk: If the purchase price in the CD&R transaction is set near the current trading level, the market may see limited residual upside post-close.
Competitive Risk: Intense competition in packaging, including moves by large peers on pricing and technology, could pressure margins in key categories.
Macro Risk: Slower industrial production or food demand during an economic slowdown would hurt volumes and cash flow.
Execution Risk: Integration or deleveraging plans under private ownership could prove more challenging than expected, especially given the companys leverage profile.

Bottom Line

Investment Verdict: BULLISH

Data suggests $SEE is favorably positioned in the near term because regulatory approvals meaningfully lower deal risk and create a clear catalyst in April. Fundamental metrics, including a 12.24 P/E and nearly 50% ROE, support a constructive view on value. That said, you should be aware that a finalized take-private price could cap longer-term public upside and that leverage and liquidity are material watch items.

Action Items for Investors

Long-term investors: Monitor the April close and any disclosures about the buyers post-close plans, and reassess exposure if the transaction price suggests limited upside beyond the deal.
Short-term traders: Watch for news flow around the acquisition closing and the Q1 2026 earnings release on 2026-05-04, which could trigger volatility near-term.
Risk management: Consider position sizing that reflects balance sheet leverage and the potential for deal-related volatility. Set clear stop rules based on your risk tolerance.

What to Watch This Week

Final confirmations related to the CD&R acquisition and any supplement to the merger agreement.
Analyst notes and price target updates following the regulatory approval and any buyer disclosures.
Short-term price action around the $44.30 resistance level and the $38 support level.

Is the pending CD&R deal the endgame for public upside, or will private equity create and reveal new value that benefits stakeholders in other ways? Will margins hold as input costs fluctuate? Those are the two strategic questions investors should keep front of mind as the transaction moves to close.

SEE: Acquisition Nears, Valuation Edge